Bal Pharma Limited has confirmed compliance with Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended December 31, 2025. This confirmation is based on certificates received from their Registrar and Transfer agent, MUFG Intime India Pvt Ltd.

The company has submitted the details of securities dematerialized or rematerialized during the quarter to all stock exchanges where its equity shares are listed, within the stipulated timeframe.

Furthermore, Bal Pharma stated that any share certificates received for dematerialization have been duly verified, mutilated, and cancelled. The name of the depository has been substituted as the registered owner in the company's records within 15 days of receiving the security certificates.